Results
1 -
10 of
24
(Click
here to explore results)
- Exploitation of the multitarget role of new ferulic and gallic acid derivatives in oxidative stress-related Alzheimer's disease therapies: design, synthesis and bioevaluation. Fahad Hussain, Ayesha Tahir, Muhammad Saeed Jan, Noor Fatima, Abdul Sadiq, Umer Rashid
, RSC Adv.
, 2024
, 14
, 10304
- Design, synthesis, biological evaluation and docking studies of sulfonyl isatin derivatives as monoamine oxidase and caspase-3 inhibitors. Mohsen Tavari, Sarel F. Malan, Jacques Joubert
, Med. Chem. Commun.
, 2016
, 7
, 1628
- An efficient method to access spiro pseudoindoxyl ketones: evaluation of indoxyl and their N-benzylated derivatives for inhibition of the activity of monoamine oxidases. Karuppaiah Perumal, Jiseong Lee, Sesuraj Babiola Annes, Subburethinam Ramesh, T. M. Rangarajan, Bijo Mathew, Hoon Kim
, RSC Adv.
, 2023
, 13
, 24925
- Isatin-based benzyloxybenzene derivatives as monoamine oxidase inhibitors with neuroprotective effect targeting neurogenerative disease treatment. Feba Benny, Jong Min Oh, Sunil Kumar, Mohamed A. Abdelgawad, Mohammed M. Ghoneim, Mohamed Sadek Abdel-Bakky, Neelima Kukerti, Jobin Jose, Hoon Kim, Bijo Mathew
, RSC Adv.
, 2023
, 13
, 35240
- Pyrazolobenzothiazine-based carbothioamides as new structural leads for the inhibition of monoamine oxidases: design, synthesis, in vitro bioevaluation and molecular docking studies. Syed Mobasher Ali Abid, Sana Aslam, Sumera Zaib, Syeda Mahwish Bakht, Matloob Ahmad, Muhammad Makshoof Athar, John M. Gardiner, Jamshed Iqbal
, Med. Chem. Commun.
, 2017
, 8
, 452
- Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies. Muhammad Aamir Javed, Saba Bibi, Muhammad Saeed Jan, Muhammad Ikram, Asma Zaidi, Umar Farooq, Abdul Sadiq, Umer Rashid
, RSC Adv.
, 2022
, 12
, 22503
- Design, synthesis and biological evaluation of light-driven on–off multitarget AChE and MAO-B inhibitors. Marco Paolino, Mariagrazia Rullo, Samuele Maramai, Modesto de Candia, Leonardo Pisani, Marco Catto, Claudia Mugnaini, Antonella Brizzi, Andrea Cappelli, Massimo Olivucci, Federico Corelli, Cosimo D. Altomare
, RSC Med. Chem.
, 2022
, 13
, 873
- Towards 4th industrial revolution efficient and sustainable continuous flow manufacturing of active pharmaceutical ingredients. Cloudius R. Sagandira, Sinazo Nqeketo, Kanyisile Mhlana, Thembela Sonti, Sibongiseni Gaqa, Paul Watts
, React. Chem. Eng.
, 2022
, 7
, 214
- Exploring coumarin potentialities: development of new enzymatic inhibitors based on the 6-methyl-3-carboxamidocoumarin scaffold. A. Fonseca, M. J. Matos, J. Reis, Y. Duarte, M. Gutiérrez, L. Santana, E. Uriarte, F. Borges
, RSC Adv.
, 2016
, 6
, 49764
- Mechanistic studies and radiofluorination of structurally diverse pharmaceuticals with spirocyclic iodonium(iii) ylides. Benjamin H. Rotstein, Lu Wang, Richard Y. Liu, Jon Patteson, Eugene E. Kwan, Neil Vasdev, Steven H. Liang
, Chem. Sci.
, 2016
, 7
, 4407